PATENT CLAIM ANALYSIS

Application Number: 16230216
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-06
Patent Classification: ["435", "070210"]

Abstract:
The present disclosure pertains to a mammalian cell culture genetically modified to express, and which expresses, a neublastin antibody polypeptide, or fragment thereof, in the culture, and to a neublastin antibody polypeptide, or fragment thereof, made by a mammalian cell culture genetically modified to express, and which expresses, the neublastin antibody polypeptide, or fragment thereof.

Claim (Index 15):
The neublastin antibody polypeptide of  claim 10 , wherein the cells have been adapted to grow in serum-free medium, an animal protein-free medium, or a chemically defined medium.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 98.0
- Lexical Diversity: 2.44444
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14589372', '13511203', '13722398', '15955393', '11665344']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5783707109688803
- 35 USC 102 Novelty (BERT): 0.5137287015563298
- Combined Prediction Score: 0.5719065100276253
- Mean Citation Score: 247.028408
- Max Citation Score: 257.55594
- Similarity Product: 168.24497365847108

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test